Remove 2024 Remove Competition Remove Pharmaceutical manufacturing Remove Safety
article thumbnail

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

pharmaphorum

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society. And so, pharmaceutical spending is an investment, he said.

article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

The global pharmaceutical manufacturing market stood at USD 405.52 billion during 2020-2024. The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. billion in 2020 and will project growth of USD 4.18 from 2023 to 2030.

Pharma 52